Your session is about to expire
← Back to Search
Device
Tympanostomy Tube Placement for Acute Otitis Media (inVENT-visIOn Trial)
N/A
Waitlist Available
Led By Jacob W. Zeiders, M.D.
Research Sponsored by Integra LifeSciences Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks post-procedure
Awards & highlights
No Placebo-Only Group
Summary
The objective of the study is to evaluate the safety and efficacy of the Acclarent Tympanostomy Tube Delivery System (TDS) for the placement of Tympanostomy Tube TT(s) under local anesthesia delivered by iontophoresis in an office/clinic setting.
Eligible Conditions
- Acute Otitis Media
- Ear Infection
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 weeks post-procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks post-procedure
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Device Success
Number of Subjects With Procedural, Serious and Device-related Adverse Events.
Secondary study objectives
Procedure Success
Procedure Tolerability
Tube Retention
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Tympanostomy Tube PlacementExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tympanostomy tube placement (Acclarent iontophoresis device)
2011
N/A
~50
Find a Location
Who is running the clinical trial?
Integra LifeSciences CorporationLead Sponsor
108 Previous Clinical Trials
11,252 Total Patients Enrolled
AcclarentIndustry Sponsor
22 Previous Clinical Trials
1,929 Total Patients Enrolled
Jacob W. Zeiders, M.D.Principal InvestigatorSouth Coast Ear, Nose & Throat
Share this study with friends
Copy Link
Messenger